SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-072392
Filing Date
2022-06-17
Accepted
2022-06-17 16:14:02
Documents
2
Period of Report
2022-06-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2217338-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2217338-1_4seq1.xml 4 11053
2 EXHIBIT 24 tm2217338-1_ex24.htm EX-24 3615
  Complete submission text file 0001104659-22-072392.txt   16173
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Issuer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ENTREMED, INC. 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
He Wei-Wu (Reporting) CIK: 0001542073 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20713 | Film No.: 221023988